Research graph
References from Reticuloendothelial system blockade-assisted redirection of celastrol-loaded nanomedicine to glomeruli for treatment of mesangioproliferative glomerulonephritis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1007/978-981-13-8871-2_1
10.1007/978-981-13-8871-2_1 · External reference
Mitochondria-targeting therapeutic strategies for chronic kidney disease
10.1016/j.bcp.2024.116669 · 2025 · External reference
Epidemiology of chronic kidney disease: An update 2022
10.1016/j.kisu.2021.11.003 · 2022 · External reference
Glomerulonephritis: Immunopathogenesis and immunotherapy
10.1038/s41577-022-00816-y · 2023 · External reference
Sublytic C5b-9 induces IL-23 and IL-36a production by glomerular mesangial cells via PCAF-mediated KLF4 acetylation in rat Thy-1 nephritis
10.4049/jimmunol.1800719 · 2018 · External reference
Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis
10.1038/s41467-017-00834-8 · 2017 · External reference
Regulation of mesangial cell proliferation
10.1046/j.1523-1755.1999.00710.x · 1999 · External reference
Chronic kidney disease as a global public health problem: Approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes
10.1038/sj.ki.5002343 · 2007 · External reference
The incidence of primary glomerulonephritis worldwide: A systematic review of the literature
10.1093/ndt/gfq665 · 2011 · External reference
The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy
10.1007/s11926-015-0513-4 · 2015 · External reference
Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment
10.1007/s12274-021-3894-x · 2022 · External reference
Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity
10.3389/fphar.2024.1137289 · 2024 · External reference
Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity
10.1016/j.jconrel.2020.01.017 · 2020 · External reference
Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio)
10.3109/01480545.2010.494664 · 2011 · External reference
Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol
10.1097/cad.0b013e3283514b68 · 2012 · External reference
Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
10.1158/0008-5472.can-05-4529 · 2006 · External reference
Biomimetic and bioinspired nanoparticles for targeted drug delivery
10.4155/tde-2017-0013 · 2017 · External reference
Recent advances in peptide-loaded PLGA nanocarriers for drug delivery and regenerative medicine
10.3390/ph18010127 · 2025 · External reference
The design of poly(lactide-co-glycolide) nanocarriers for medical applications
10.3389/fbioe.2020.00048 · 2020 · External reference
Nanotherapeutics in kidney disease: Innovations, challenges, and future directions
10.1681/asn.0000000608 · 2025 · External reference
Targeting kidney mesangium by nanoparticles of defined size
10.1073/pnas.1103573108 · 2011 · External reference
Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions
10.1016/j.jconrel.2021.04.016 · 2021 · External reference
Coassembly of cell-penetrating peptide octaarginine with acetazolamide: Emergent interactions with E. coli
10.1021/acsomega.4c06800 · 2024 · External reference
Octaarginine-modified liposomes: Enhanced cellular uptake and controlled intracellular trafficking
10.1016/j.ijpharm.2007.12.003 · 2008 · External reference
Intracellular delivery of oxaliplatin conjugate via cell penetrating peptide for the treatment of colorectal carcinoma in vitro and in vivo
10.1016/j.ijpharm.2021.120904 · 2021 · External reference
Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting
10.1016/j.biomaterials.2014.02.031 · 2014 · External reference
Octaarginine-modified gold nanoparticles enhance the radiosensitivity of human colorectal cancer cell line LS180 to megavoltage radiation
10.2147/ijn.s161157 · 2018 · External reference
Analysis of nanoparticle delivery to tumours
10.1038/natrevmats.2016.14 · 2016 · External reference
Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach
10.1021/acsnano.9b08142 · 2020 · External reference
Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with stiff nanogels
10.1038/s41467-023-37150-3 · 2023 · External reference
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination
10.1016/j.jconrel.2016.01.020 · 2016 · External reference
Improved tumor uptake by optimizing liposome based RES blockade strategy
10.7150/thno.18078 · 2017 · External reference
Overcoming the reticuloendothelial system barrier to drug delivery with a "Don't-Eat-Us" strategy
10.1021/acsnano.9b05679 · 2019 · External reference
Enhancing doxorubicin delivery toward tumor by hydroxyethyl starch-g-polylactide partner nanocarriers
10.1021/acsami.7b00048 · 2017 · External reference
Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery
10.1021/acsami.7b16524 · 2018 · External reference
Suppressive effects of GTW treatment on infiltration of inflammatory cell in glomeruli in anti-Thy1.1 glomerulonephritis
10.3321/j.issn:1001-5302.2009.01.020 · 2009 · External reference
Role and potential of histopathological specimens in the toxicological evaluation of pharmaceuticals and chemicals
10.1254/fpj.21102 · 2022 · External reference
Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories
10.1002/jbm.b.33648 · 2017 · External reference
The recent insight in the release of anticancer drug loaded into PLGA microspheres
10.1007/s12032-023-02103-9 · 2023 · External reference
Phenomenology of the initial burst release of drugs from PLGA microparticles
10.1021/acsbiomaterials.0c01228 · 2020 · External reference
Increasing resonance energy transfer upon dilution: A counterintuitive observation in CTAB micelles
10.1039/d1tc02888j · 2021 · External reference
Reticuloendothelial system pre-block strategy to improve tumor targeting efficacy for hyaluronic acid related drug delivery system
10.1166/jbn.2018.2603 · 2018 · External reference
Clearance pathways and tumor targeting of imaging nanoparticles
10.1021/acsnano.5b01320 · 2015 · External reference
Monocyte membrane-fused liposomes for enhanced targeted treatment of mesangioproliferative glomerulonephritis
10.1021/acsami.5c18857 · 2025 · External reference
Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis
10.4049/jimmunol.150.3.1074 · 1993 · External reference
Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis
10.1038/ki.1997.108 · 1997 · External reference
Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis
1993 · External reference
Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis
1997 · External reference
Nanotechnology-based celastrol formulations and their therapeutic applications
10.3389/fphar.2021.673209 · 2021 · External reference
Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
10.3390/polym3031377 · 2011 · External reference
